New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol)

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 21, Issue 3

Abstract

Background: Amanita phalloides (Amanita) contains amanitin, inhibiting RNA polymerase II. Partial inhibition with amanitin influences tumor cell - but not normal cell - activity. Patients treated with Amanita often gain a stable disease state without further tumor growth. Aim: Several therapies for prostate cancer are in use so far. This study evaluates the implementation of the Amanita therapy into the therapeutic regimen of today. Methods: 38 Patients with diagnosed prostate cancer were treated with Amanita alone. Prostate specific antigen (PSA) was used as a parameter for tumor cell growth. Data about previous therapies like anti androgen treatment, prostatectomy, chemotherapy or radiation and progression state of the disease were collected, and relationships analyzed. Results: Some patients could be stabilized with Amanita, evidenced by previously increasing PSA that did not increase for at least six months during Amanita therapy. In some patients PSA levels further increased despite Amanita therapy indicating immediate therapy resistance. Analyses revealed that successful Amanita therapy is strongly associated with beginning therapy early, while progressive disease states are often resistant to Amanita (p-value 0,005). Correlation between tumor specific pre-treatments and Amanita therapy resistance is significant: all patients without pre-treatment could be stabilized with Amanita (p-value 0,007). Conclusions: Amanita therapy can reduce tumor growth best in patients without previous treatments, and was most effective in patients without tumor progression. Therefore Amanita should be used first as a tumor specific therapy. Anti androgen treatment, chemotherapy, radiation or prostatectomy can be applied at later stages.

Authors and Affiliations

Isolde Riede

Keywords

Related Articles

Alteration of Sex Hormone and Semen Parameters in Adult Males with Subclinical Hypothyroidism

Aim: To investigate the correlation between subclinical hypothyroidism (SCH) with serum testosterone levels and semen parameters (sperm count, total motility and morphology) in men seeking medical care for sexual dysfunc...

Risk Factors of Musculoskeletal Disorders in Dental Students – A Qualitative Study

Aim: To use a focus group to determine dentistry students' perceptions of risk factors involved in developing musculoskeletal disorders. Study Design: This is a qualitative and observational study with a non-probability...

Brain Derived Neurotrophic Growth Factor and Cognitive Function in Children with Iron Deficiency Anemia

Background: The negative effects of iron deficiency anemia (IDA) on cognition are well documented in previous studies; however, distinct mechanisms of these effects are still a matter of debate. Brain derived neurotrophi...

Liver Protein and Enzymes in HIV Infected Pregnant and Non-pregnant Women on Antiretroviral Therapy

This in vivo study was carried out to investigate alterations in the levels of proteins and enzymes produced by the liver of HIV infected pregnant women and HIV infected non pregnant women under different antiretroviral...

Why Endometriosis Causes Infertility?

Endometriosis is a common disorder of reproductive age group, defined as the presence of endometrial glands and stroma outside the lining of the uterus. The disease carries enormous medical and economic burden on the soc...

Download PDF file
  • EP ID EP311867
  • DOI 10.9734/BJMMR/2017/32673
  • Views 49
  • Downloads 0

How To Cite

Isolde Riede (2017). New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol). Journal of Advances in Medicine and Medical Research, 21(3), 1-7. https://europub.co.uk/articles/-A-311867